ARS Pharmaceuticals, Inc. (SPRY)
9.01
-0.06
(-0.66%)
USD |
NASDAQ |
Jun 01, 09:50
ARS Pharmaceuticals Shareholders Equity (Quarterly) : 61.31M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | -217.14M |
| Heron Therapeutics, Inc. | 9.137M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Anika Therapeutics, Inc. | 133.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 287.57M |
| Total Liabilities (Quarterly) | 226.26M |
| Debt to Equity Ratio | 1.584 |
| Current Ratio | 4.943 |
| Net Debt Paydown Yield | -2.43% |